China Resources Double-Crane Pharmaceutical Co Ltd (600062) Cash Flow Statement

A cash flow statement shows the actual cash a company generated and spent across operating, investing, and financing activities over a reporting period.

China Resources Double-Crane Pharmaceutical Co.,Ltd. operates as a pharmaceutical company in the People's Republic of China.

Total Cash From Operating Activities Chart for China Resources Double-Crane Pharmaceutical Co Ltd

China Resources Double-Crane Pharmaceutical Co Ltd (600062) operating cash flow for FY2025 was CNY 1.5B, a -18.4% change from FY2024. China Resources Double-Crane Pharmaceutical Co Ltd's operating cash flow moved from CNY -13.8M in 1998 to CNY 1.5B in 2025 over 27 years. Operating cash flow compound annual growth rate: 5-year CAGR of 1.8%, 10-year CAGR of 7.8%, 20-year CAGR of 12.6%.

The most recent 3 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.